Keywords: CEST / APT / NOE, Alzheimer's Disease, NAD+
Motivation: Neurodegenerative diseases, particularly Alzheimer's, involve disrupted NAD+ and purine metabolic pathways. Understanding these disruptions can improve diagnostic sensitivity for clinical applications, especially using CEST MRI.
Goal(s): To characterise in-vitro CEST MRI properties of NAD+ and its biosynthesis precursors, focusing on sensitivity for neurodegenerative disease biomarkers linked to NAD+/purine metabolism.
Approach: In-vitro CEST MRI was used to analyse NAD+ and biosynthesis precursors, quantifying, characterising, and assigning distinct proton peaks to assess sensitivity as neurodegenerative disease biomarkers.
Results: High CEST contrast was achieved for NMN and NAD+, with NAD+ showing pH-dependent effects and up to 15% CEST contrast for its amine moiety (2.03ppm).
Impact: This study may impact neurodegenerative disease research by enabling precise CEST MRI-based tracking of NAD+ metabolism, specifically adenosine-linked pathways as elucidated (2.03ppm). This could deepen understanding of metabolic disruptions, opening new avenues for early diagnosis and targeted therapeutic monitoring.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords